CORD-19:ee0a7632371a08727d41e55aad7d621daeceef7d / 351777-352204 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"T84063","span":{"begin":0,"end":427},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"ACL LDT HIVING produced 90% clinical sensitivity (18/19) and specificity (19/21) all samples were genotype M, subtype B (40) with viral loads ranging from (1000 to 150,000 cp/mL), analytical sensitivity 100% at VL=1000 cp/mL for HIV subtypes (B, G, C, CRF01_AE) and per in silico analysis HIV genotypes (D, F, A, CRF02_AG), analytical specificity 100% (11/11) in comparison to potentially cross-reactive microorganisms/viruses."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T298","span":{"begin":0,"end":427},"obj":"Sentence"}],"text":"ACL LDT HIVING produced 90% clinical sensitivity (18/19) and specificity (19/21) all samples were genotype M, subtype B (40) with viral loads ranging from (1000 to 150,000 cp/mL), analytical sensitivity 100% at VL=1000 cp/mL for HIV subtypes (B, G, C, CRF01_AE) and per in silico analysis HIV genotypes (D, F, A, CRF02_AG), analytical specificity 100% (11/11) in comparison to potentially cross-reactive microorganisms/viruses."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T2010","span":{"begin":211,"end":213},"obj":"Disease"},{"id":"T98999","span":{"begin":211,"end":213},"obj":"Disease"}],"attributes":[{"id":"A2010","pred":"mondo_id","subj":"T2010","obj":"http://purl.obolibrary.org/obo/MONDO_0024555"},{"id":"A59016","pred":"mondo_id","subj":"T98999","obj":"http://purl.obolibrary.org/obo/MONDO_0024555"}],"text":"ACL LDT HIVING produced 90% clinical sensitivity (18/19) and specificity (19/21) all samples were genotype M, subtype B (40) with viral loads ranging from (1000 to 150,000 cp/mL), analytical sensitivity 100% at VL=1000 cp/mL for HIV subtypes (B, G, C, CRF01_AE) and per in silico analysis HIV genotypes (D, F, A, CRF02_AG), analytical specificity 100% (11/11) in comparison to potentially cross-reactive microorganisms/viruses."}